Supplements

Meeting Highlights: Cardiovascular Research Technologies 2019

Publish date: May 14, 2019
A supplement to Cardiology News. This supplement is sponsored by Chiesi USA, Inc.
PDF Download

 

A supplement to Cardiology News. This supplement was sponsored by Chiesi USA, Inc.

News included in the supplement:

  • Ultrathin stent loses advantage at 3 years
  • Adjunctive devices for TAVR boost outcomes
  • MI alert device shows predictive value
  • Readmissions high post STEMI with cardiogenic shock
  • Endovascular device sustains BP reductions
  • Alcohol renal denervation safe for BP reduction

Recommended Reading

AFib screening cuts hospitalizations and ED visits
MDedge Cardiology
CardioMEMS cuts heart failure hospitalizations in post-approval study
MDedge Cardiology
Pilot program trains residents in telemedicine
MDedge Cardiology
Various adjuncts to IVIg help treat coronary artery abnormalities in pediatric Kawasaki disease
MDedge Cardiology
Higher plasma cell-free DNA tracks with worse PAH survival
MDedge Cardiology
Canagliflozin after metabolic surgery may aid weight loss, reduce glucose levels
MDedge Cardiology
Ankylosing spondylitis patients taking COX-2 inhibitors may see fewer cardiovascular events
MDedge Cardiology
Type 2 diabetes remission: Reducing excess fat in the liver might be the key
MDedge Cardiology
Arsenic exposure increases risk of left ventricular hypertrophy
MDedge Cardiology
Severe OSA increases cardiovascular risk after surgery
MDedge Cardiology